Page 30 - Sanket Koul

CDSCO flags 135 drugs for failing quality standards for December 2024

Most drugs found NSQ by central labs this month were produced in units located in cities such as Ahmedabad, Vadodara, Himachal Pradesh's Baddi, Puducherry, Roorkee and Haridwar

Mankind Pharma Q3FY25 results: PAT falls 16.5%, revenue rises 24%

Mankind's revenue from operations rose to Rs 3,230 crore in Q3FY25, a 24 per cent Y-o-Y rise from Rs 2,607 crore reported in Q3FY24

Dr Reddy's Labs Q3 results: PAT rises 2.5% at Rs 1,413 cr, revenue up 16%

The growth was largely driven by revenue from its recently acquired nicotine replacement therapy (NRT) portfolio and performance in the European and emerging markets

Union cabinet extends National Health Mission for another 5 years

Govt says India on track to meet SDG health targets well before 2030 deadline

Centre looking to expand network of stroke units, says health secy

The medtech industry is also looking for an opening in stroke care, with experts suggesting collaborations such as public-private partnerships (PPP)

US withdrawal from WHO unfortunate, but won't affect India: Health experts

This follows US President Donald Trump's signing of an executive order on Monday, announcing the country's withdrawal from the WHO

MedTech industry divided over move to stop imports of refurbished devices

Domestic manufacturers added that the order will also stop the unregulated influx of second hand medical devices which could have been detrimental to the patient safety in India

CDSCO to disallow import of pre-owned, refurbished med devices into India

Health Ministry to constitute expert committee, import suspended until policy framework is finalised

Medtech sector seeks standard GST rate, export incentives in Budget

The scheme aims to refund to exporters the embedded central, state, and local duties and taxes paid on inputs that were so far not refunded or rebated

Odisha joins Ayushman Bharat-PMJAY scheme, signs MoU with Centre

The Centre's flagship health scheme will run in convergence with the state's Gopabandhu Jan Arogya Yojana (GJAY)

Small, medium-sized pharma firms gear up to comply with revised Schedule M

Pharma groups had wanted two year extension, will raise concerns with govt

Medtech industry expects regulatory body to reclassify more medical devices

CDSCO to initiate workshops; industry says step will bring regulatory uniformity

'A milestone': PM Narendra Modi unveils genome data of 10K Indians

Genome sequencing, a laboratory technique used to decode the entire genetic composition of an organism or cell type, lies at the heart of the project

US pharma major Eli Lilly to establish second Indian GCC in Hyderabad

Company plans to employ 1,000-1,500 skilled professionals; GCC to focus on automation, AI

HMPV scare: Centre asks states to enhance surveillance, create awareness

Seven HMPV cases detected in India; health secretary says country prepared for any potential surge in respiratory illness cases

HMPV outbreak: India reports 5 cases, govt says there's no need to panic

Health Min says current data shows no unusual surge in influenza-like respiratory illnesses

No unusual rise in flu-like cases in India, says govt amid China HMPV surge

Health Ministry convenes monitoring group meeting over hMPV surge in China

MSME Pharma units get breather as govt extends Schedule M deadline

Pharma cos with turnover of Rs 250 cr or less can submit an application to the central drugs regulator for one one-year extension

Budget wishlist: Pharma firms seek simplified taxes, stronger PLI scheme

Among other demands is the removal of Section 194R related to marketing samples that would ease business operations

No cause for alarm: Indian health officials on hMPV spread in China

The National Centre for Disease Control (NCDC) is also monitoring respiratory and seasonal influenza cases, official sources told news agency ANI